KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc.verified

600422.SS

Price:

$12.64

Market Cap:

$9.57B

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, an...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-12-06

Stock Exchange

SHH

Ticker

600422.SS

The Enterprise Value as of December 2025 (TTM) for KPC Pharmaceuticals, Inc. (600422.SS) is 10.59B

According to KPC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.59B. This represents a change of -8.92% compared to the average of 11.63B of the last 4 quarters.

KPC Pharmaceuticals, Inc. (600422.SS) Historical Enterprise Value (quarterly & annually)

How has 600422.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of KPC Pharmaceuticals, Inc. over the last ten years is 9.36B. The current 10.59B Enterprise Value has changed 11.21% with respect to the historical average. Over the past ten years (40 quarters), 600422.SS's Enterprise Value was at its highest in in the March 2024 quarter at 16.08B. The Enterprise Value was at its lowest in in the December 2018 quarter at 4.23B.

Quarterly (TTM)
Annual

Average

9.36B

Median

8.86B

Minimum

4.12B

Maximum

15.44B

KPC Pharmaceuticals, Inc. (600422.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of KPC Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 81.97%

Maximum Annual Enterprise Value = 15.44B

Minimum Annual Increase = -41.78%

Minimum Annual Enterprise Value = 4.12B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202410.43B-31.36%
202315.20B50.62%
202210.09B32.20%
20217.63B31.11%
20205.82B-22.43%
20197.50B81.97%
20184.12B-41.78%
20177.08B-31.39%
201610.32B-33.12%
201515.44B65.23%

KPC Pharmaceuticals, Inc. (600422.SS) Average Enterprise Value

How has 600422.SS Enterprise Value performed in the past?

The current Enterprise Value of KPC Pharmaceuticals, Inc. (600422.SS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

11.91B

5-year avg

9.83B

10-year avg

9.36B

KPC Pharmaceuticals, Inc. (600422.SS) Enterprise Value vs. Peers

How is 600422.SS’s Enterprise Value compared to its peers?

KPC Pharmaceuticals, Inc.’s Enterprise Value is greater than Cisen Pharmaceutical Co., Ltd. (7.79B), greater than Tianjin Ringpu Bio-Technology Co.,Ltd. (10.07B), greater than Harbin Pharmaceutical Group Co., Ltd. (9.01B), greater than Shandong Xinhua Pharmaceutical Company Limited (8.75B), less than North China Pharmaceutical Company Ltd. (19.51B), greater than Zhejiang Hisoar Pharmaceutical Co., Ltd. (9.50B), greater than Zhejiang Xianju Pharmaceutical Co.,Ltd. (8.29B), greater than Renhe Pharmacy Co., Ltd. (7.32B), greater than Changzhou Qianhong Biopharma CO.,LTD (9.58B), greater than Northeast Pharmaceutical Group Co., Ltd. (8.14B),

Build a custom stock screener for KPC Pharmaceuticals, Inc. (600422.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like KPC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

KPC Pharmaceuticals, Inc. (600422.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like KPC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is KPC Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for KPC Pharmaceuticals, Inc. (600422.SS)?

What is the 3-year average Enterprise Value for KPC Pharmaceuticals, Inc. (600422.SS)?

What is the 5-year average Enterprise Value for KPC Pharmaceuticals, Inc. (600422.SS)?

How does the current Enterprise Value for KPC Pharmaceuticals, Inc. (600422.SS) compare to its historical average?